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In spite of hundreds of attempts over the last century, Paul Ehrlich’s dream of the “magic bullet” targeted 
delivery system still has not been realized. Yet these studies have clearly identified the many technological 
barriers that prevent success. This presentation will describe a step-by-step progression that converted an 
unstable, non-functional viral capsid (a virus-like particle, VLP) into a sophisticated nanoparticle for targeted 
delivery of drugs, nucleic acids, and proteins.  
 
Initial mutations reduced immunogenicity and antigenicity and provided a new conditional stability that still 
allows the VLP to disassembly inside the targeted cell to release its cargo. A hexa-histidine tag enables 
purification of cell-free produced VLP subunits while potentially also serving to trigger endosomal escape by the 
“proton sponge” effect. The subunits are also extended with a cargo adsorption domain so that simultaneous 
cargo loading and VLP assembly can be triggered by increasing ionic strength.  Finally the VLP subunit protein 
was further mutated to incorporate non-natural amino acids which then enable precise surface modification by 
attaching scFv antibody fragments as targeting agents as well as the extracellular domain of the CD47 receptor 
to avoid immune system interception. To provide an authentic CD47 interactive surface, the ECD has a 
pyroglutamate N-terminus, two point attachment (mostly) to the VLP surface, and improved solubility. Functional 
evaluations using cultured cells are promising and results from initial animal studies will be described.   
 
 
